AMGEN Inc.

NASDAQ:AMGN   3:59:59 PM EDT
230.01
-2.45 (-1.05%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)132.85B
Current PE18.29
Forward PE 13.65
2yr Forward PE 12.61
See more stats
Estimates Current Quarter
Revenue$6.3 Billion
Adjusted EPS$4.08
See more estimates
10-Day MA$232.67
50-Day MA$234.68
200-Day MA$234.10
See more pivots

Amgen, Inc. Stock, NASDAQ:AMGN

One Amgen Center Drive, Thousand Oaks, California 91320-1799
United States of America
Phone: +1.805.447.1000
Number of Employees: 24300

Description

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.